(Q37279662)

English

Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial

scientific article published on 19 September 2016

Statements

Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial (English)
19 September 2016

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit